Obi Greenman
Algemeen Directeur bij CERUS CORPORATION
Vermogen: 5 M $ op 31-05-2024
Actieve functies van Obi Greenman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CERUS CORPORATION | Directeur/Bestuurslid | 21-04-2011 | - |
| Algemeen Directeur | 21-04-2011 | - | |
| President | 21-04-2011 | - | |
| Corporate Officer/Principal | 01-01-1999 | 01-08-2008 | |
| Verkoop & Marketing | 01-08-2008 | 21-04-2011 |
Loopbaan van Obi Greenman
Eerdere bekende functies van Obi Greenman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| CHINOOK THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-06-2010 | 11-08-2023 |
| Independent Dir/Board Member | 01-06-2010 | 11-08-2023 | |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01-01-1995 | 01-01-1995 |
| CHINOOK THERAPEUTICS, INC. | Directeur/Bestuurslid | 23-06-2011 | - |
| Independent Dir/Board Member | 01-06-2010 | - |
Opleiding van Obi Greenman
| Stanford University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Independent Dir/Board Member | 2 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CERUS CORPORATION | Health Technology |
| BAXTER INTERNATIONAL INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Aduro BioTech, Inc.
 Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
Chinook Therapeutics, Inc.
 Chinook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA. | Health Technology |
- Beurs
- Insiders
- Obi Greenman
- Ervaring
